Author

Meet Parmar

Indian Institute of Advanced Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:deep learning· 1 Approach:mixed model· 1 Assay:protein sequence· 1 Assay:protein structure· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

Dhaval PateliD· 2 shared Ritik Thumar· 2 shared Alastair James SloaniD· 1 shared Andrew HungiD· 1 shared Aydın Menekşe· 1 shared Bhumi Patel· 1 shared Jigar Sheth· 1 shared Kevion K. DarmawaniD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Dhaval PatelORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Computational evolutionary approach to generate antimicrobial peptides

Timothy Harrison, Tianmeng Zhang, Meet Parmar, Praveen Praveen, Aydın Menekşe, Kevion K. Darmawan, Alastair James Sloan, Wei Xiang, Andrew Hung, Wenyi Li

This study uses deep learning and evolutionary methods to design antimicrobial peptides with selective activity against specific bacteria.

bioRxiv · Jul 28, 2026 · PreprintBiochemistry

Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches.

Meet Parmar, Ritik Thumar, Jigar Sheth, Dhaval Patel

This study designs a multi-epitope peptide vaccine targeting the SARS-CoV-2 Omicron variant using computational methods to predict epitopes and evaluate vaccine properties.

Structural Chemistry · Sep 19, 2022Peer-reviewedBioinformatics

Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights For Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics Simulations.

Meet Parmar, Ritik Thumar, Bhumi Patel, Mohd Athar, Prakash Chandra Jha, Dhaval Patel

This paper compares SARS-CoV-2 and SARS-CoV Mpro using molecular dynamics simulations to assess structural differences and their impact on drug repurposing for COVID-19.

bioRxiv · Aug 11, 2021 · PreprintBioinformatics